MENLO PARK, CA -- (MARKET WIRE) -- April 04, 2007 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that a Nasdaq Listing Qualifications Panel has granted the company's request to be listed on the Nasdaq Capital Market, effective with the market opening on Monday, April 9, 2007. By transferring from the Nasdaq Global Market to the Nasdaq Capital Market, Corcept satisfies all listing requirements. The Company's trading symbol will remain CORT.
